Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferationLinsheng Zhang(Johns Hopkins University), Alan D. Friedman(Johns Hopkins University)BloodNovember 14, 200710.1182/blood-2007-08-109702Cited by 66SaveCiteExport RISWatch citationsRelated PapersPSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny|Cancer Immunology Immunotherapy|2025|1